Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production. 2017

Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; olsonmr@iupui.edu mkaplan2@iupui.edu.

IL-2 is a pleiotropic cytokine that promotes the differentiation of Th cell subsets, including Th1, Th2, and Th9 cells, but it impairs the development of Th17 and T follicular helper cells. Although IL-2 is produced by all polarized Th subsets to some level, how it impacts cytokine production when effector T cells are restimulated is unknown. We show in this article that Golgi transport inhibitors (GTIs) blocked IL-9 production. Mechanistically, GTIs blocked secretion of IL-2 that normally feeds back in a paracrine manner to promote STAT5 activation and IL-9 production. IL-2 feedback had no effect on Th1- or Th17-signature cytokine production, but it promoted Th2- and Th9-associated cytokine expression. These data suggest that the use of GTIs results in an underestimation of the presence of type 2 cytokine-secreting cells and highlight IL-2 as a critical component in optimal cytokine production by Th2 and Th9 cells in vitro and in vivo.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008985 Monensin An antiprotozoal agent produced by Streptomyces cinnamonensis. It exerts its effect during the development of first-generation trophozoites into first-generation schizonts within the intestinal epithelial cells. It does not interfere with hosts' development of acquired immunity to the majority of coccidial species. Monensin is a sodium and proton selective ionophore and is widely used as such in biochemical studies. Coban,Monensin Monosodium Salt,Monensin Sodium,Monensin-A-Sodium Complex,Rumensin,Monensin A Sodium Complex
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D016906 Interleukin-9 A multifunctional cytokine secreted by primarily by activated TH2 CELLS that may play a role as a regulator of allergic INFLAMMATION. It has been shown to enhance the growth and CELL DIFFERENTIATION of MAST CELLS, and can act on a variety of other immune cells. IL-9,P40 T-Cell Growth Factor,T-Cell Growth Factor P40,IL9,Interleukin 9,P40 T Cell Growth Factor,T Cell Growth Factor P40
D050799 STAT5 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA. Mammary Gland Factor,Mammary Gland-Specific Nuclear Factor,STAT5 Protein,STAT5a Protein,STAT5a Transcription Factor,STAT5alpha Protein,STAT5b Protein,STAT5b Transcription Factor,STAT5beta Protein,Signal Transducer and Activator of Transcription 5,Signal Transducer and Activator of Transcription 5A,Signal Transducer and Activator of Transcription 5B,Factor, STAT5 Transcription,Mammary Gland Specific Nuclear Factor,Transcription Factor, STAT5,Transcription Factor, STAT5a,Transcription Factor, STAT5b

Related Publications

Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
February 2007, European journal of immunology,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
April 2020, Science immunology,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
August 1990, Journal of immunology (Baltimore, Md. : 1950),
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
August 1990, Immunology,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
September 2018, eLife,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
February 2000, European journal of immunology,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
January 1999, Journal of immunology (Baltimore, Md. : 1950),
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
January 1984, Veterinary immunology and immunopathology,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
September 2015, The Journal of clinical investigation,
Matthew R Olson, and Benjamin J Ulrich, and Sarah A Hummel, and Ibrahim Khan, and Brice Meuris, and Yesesri Cherukuri, and Alexander L Dent, and Sarath Chandra Janga, and Mark H Kaplan
May 2002, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!